Pfizer has selected Oracle Health Sciences InForm Cloud Service and Siebel Clinical Trial Management and Monitoring Cloud Service to help manage and monitor its more than 300 clinical trials a year.

The InForm Cloud Service is designed to provide greater control over data and provide efficiency and productivity gains in data management and remote monitoring. It also provides study templates and library management capabilities within InForm to help accelerate the study-build process and result in faster trial implementation.

Pfizer will also use Oracle’s Siebel Clinical Trial Management and Monitoring Cloud Service, including Oracle’s Clinical Trial Management System, Clinical Development Analytics, and risk-based monitoring (RBM) functionality. This single set of tools for internal and outsourced trials aims to simplify data exchange and the interface between investigator sites, CRO partners, and Pfizer. With the selection of Oracle’s platform and RBM solution, Pfizer will be able to execute risk-based monitoring through an integrated approach.

“Oracle Health Sciences InForm Cloud Service and Oracle Siebel Clinical Trial Management and Monitoring Cloud Service can simplify how we manage both operational and study data for in-house as well as outsourced studies,” said Rob Goodwin, vice president of Pfizer Global Product Development, Center of Excellence. “Clinical teams will be able to access study data through Oracle’s single platform cloud service, eliminating the need to send data back and forth to CROs, saving us time and reducing the cost of our clinical studies.” 

“Today, pharma companies are challenged by increasingly complex global clinical trials,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “With more than 15 years of electronic data capture experience in the clinical industry, Oracle Health Sciences helps leading pharma companies not only to standardize and optimize their clinical study processes, but also to be prepared with value-based clinical innovation solutions that enable them for the future of data collection.”